Product Licensing

Pharmaceutical company acquires access to TrueClone Collection

Published in Gene Therapy Weekly, March 17th, 2005

OriGene Technologies Inc. announced that Novasite Pharmaceuticals has licensed a subscription access to their TrueClone Collection of 24,000 full-length human cDNAs suitable for transfection and high throughput functional analyses.

"We are pleased to formalize our relationship with OriGene. We have found their TrueClone collection to be the best answer to expanding needs within the pharmaceutical industry to access readily available full-length human cDNAs for multiple drug targets in a timely and reliable manner," said Juan Ballesteros, chief scientific officer of Novasite.

Ballesteros continued, "The OriGene TrueClone collection will complement our...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-03-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry